Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma

Published:2015 Issue:14 Volume:21 Page:4268
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Lee Min-Young

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference30 articles.

1. The Changing Face of Esophageal Cancer

2. Cancer statistics, 2013

3. Esophageal Cancer

4. Esophageal cancer: chemotherapy as palliative therapy

5. Grünberger B, Raderer M, Schmidinger M, Hejna M. Palliative chemotherapy for recurrent and metastatic esophageal cancer. Anticancer Res 2007;27:2705-2714.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic effects of BAY606583 on docetaxel in esophageal cancer through modulation of ERK1/2;Cell Biochemistry and Function;2022-06-27

2. Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma;World Journal of Clinical Cases;2022-04-16

3. Second-line pembrolizumab versus chemotherapy in Japanese patients with advanced esophageal cancer: subgroup analysis from KEYNOTE-181;Esophagus;2021-09-30

4. Docetaxel Toxicity Optimization in Esophageal Squamous Cell Carcinoma Cell Line YM-1: A Study of Cell Cycle and Doubling Time Effect;Medical Laboratory Journal;2021-03-01

5. Simultaneous triple cancer of the esophagus, pancreas and rectum treated with multimodal strategies: a case report;Surgical Case Reports;2020-10-02